###begin article-title 0
###xml 104 109 <span type="species:ncbi:9606">Women</span>
Tissue-Specific Increases in 11beta-Hydroxysteroid Dehydrogenase Type 1 in Normal Weight Postmenopausal Women
###end article-title 0
###begin p 1
Conceived and designed the experiments: TCA MS CM TO. Performed the experiments: TCA KS RA MS CM. Analyzed the data: TCA KS RA JB BRW CM TO. Contributed reagents/materials/analysis tools: RA BRW CM TO. Wrote the paper: TCA KS RA JB BRW CM TO.
###end p 1
###begin p 2
###xml 1154 1155 1132 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1299 1300 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1482 1483 1454 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 107 112 <span type="species:ncbi:9606">women</span>
###xml 656 661 <span type="species:ncbi:9606">women</span>
###xml 695 700 <span type="species:ncbi:9606">women</span>
###xml 766 771 <span type="species:ncbi:9606">women</span>
###xml 792 804 <span type="species:ncbi:9606">participants</span>
###xml 1104 1109 <span type="species:ncbi:9606">women</span>
###xml 1131 1136 <span type="species:ncbi:9606">women</span>
###xml 1234 1239 <span type="species:ncbi:9606">women</span>
###xml 1405 1410 <span type="species:ncbi:9606">women</span>
###xml 1432 1437 <span type="species:ncbi:9606">women</span>
###xml 1644 1649 <span type="species:ncbi:9606">women</span>
###xml 1789 1794 <span type="species:ncbi:9606">women</span>
With age and menopause there is a shift in adipose distribution from gluteo-femoral to abdominal depots in women. Associated with this redistribution of fat are increased risks of type 2 diabetes and cardiovascular disease. Glucocorticoids influence body composition, and 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) which converts inert cortisone to active cortisol is a putative key mediator of metabolic complications in obesity. Increased 11betaHSD1 in adipose tissue may contribute to postmenopausal central obesity. We hypothesized that tissue-specific 11betaHSD1 gene expression and activity are up-regulated in the older, postmenopausal women compared to young, premenopausal women. Twenty-three pre- and 23 postmenopausal, healthy, normal weight women were recruited. The participants underwent a urine collection, a subcutaneous adipose tissue biopsy and the hepatic 11betaHSD1 activity was estimated by the serum cortisol response after an oral dose of cortisone. Urinary (5alpha-tetrahydrocortisol+5beta-tetrahydrocortisol)/tetrahydrocortisone ratios were higher in postmenopausal women versus premenopausal women in luteal phase (P<0.05), indicating an increased whole-body 11betaHSD1 activity. Postmenopausal women had higher 11betaHSD1 gene expression in subcutaneous fat (P<0.05). Hepatic first pass conversion of oral cortisone to cortisol was also increased in postmenopausal women versus premenopausal women in follicular phase of the menstrual cycle (P<0.01, at 30 min post cortisone ingestion), suggesting higher hepatic 11betaHSD1 activity. In conclusion, our results indicate that postmenopausal normal weight women have increased 11betaHSD1 activity in adipose tissue and liver. This may contribute to metabolic dysfunctions with menopause and ageing in women.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Bjorkelund1">[1]</xref>
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Shen1">[2]</xref>
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Carr1">[3]</xref>
###xml 281 284 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Yusuf1">[4]</xref>
###xml 411 414 411 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Mendelsohn1">[5]</xref>
###xml 567 570 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Walker1">[6]</xref>
###xml 28 33 <span type="species:ncbi:9606">women</span>
With age, and menopause, in women there is a shift in adipose distribution from gluteo-femoral to abdominal depots [1], [2]. Abdominal fat accumulation, and menopause per se, links to an increased risk of insulin resistance, type 2 diabetes, and future cardiovascular disease [3], [4]. The decrease in estradiol (E2) levels that occur with menopause might be an underlying factor of these dysmetabolic features [5]. However, other steroid hormones, notably glucocorticoids, may directly or indirectly influence body composition and the risk of cardiovascular disease [6].
###end p 4
###begin p 5
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Seckl1">[7]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Mattsson1">[8]</xref>
###xml 628 631 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Walker1">[6]</xref>
Circulating cortisol levels are tightly controlled by forward drive through hypothalamic-pituitary factors and negative feedback by cortisol[7]. Glucocorticoid excess due to tumours producing ACTH or cortisol, as occurs in Cushing's syndrome, causes central obesity, type 2 diabetes, and cardiovascular disease. In idiopathic obesity, circulating cortisol levels are essentially normal, although there may be a subtle impairment in the negative feedback by endogenous cortisol [8]. However, it has been suggested that changes in glucocorticoid metabolism may contribute to a Cushing's-like phenotype linked to abdominal obesity [6].
###end p 5
###begin p 6
###xml 208 211 202 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Seckl1">[7]</xref>
###xml 444 447 432 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Seckl1">[7]</xref>
###xml 556 559 541 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Walker1">[6]</xref>
###xml 561 564 546 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask1">[9]</xref>
###xml 783 787 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Morton1">[10]</xref>
###xml 920 924 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Masuzaki1">[11]</xref>
###xml 926 930 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Masuzaki2">[12]</xref>
###xml 1111 1115 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Paterson1">[13]</xref>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
The availability of active glucocorticoid in different tissues is modulated through enzymatic interconversion between cortisone and cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and 2 (11betaHSD1/2) [7]. 11betaHSD1 activates cortisone to cortisol and is widely expressed with high expression in liver, adipose tissue and lung. 11betaHSD2 perform the opposite reaction and is present in mineralocorticoid target tissues e.g. the kidney [7]. In idiopathic obesity, 11betaHSD1 levels are increased in subcutaneous adipose tissue and reduced in liver [6], [9]. The physiological relevance of alterations in the activity of this enzyme has been demonstrated in several animal models. 11betaHSD1 knockout mice are protected from visceral fat accumulation when fed a high-fat diet [10], while selective over-expression of 11betaHSD1 in adipose tissue results in abdominal obesity, insulin resistance, and hypertension [11], [12]. Liver-specific over-expression of the enzyme results in a non-obese phenotype with increased hepatic fat content linked to mild insulin resistance, dyslipidemia, and hypertension [13].
###end p 6
###begin p 7
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Kalleinen1">[14]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Finken1">[15]</xref>
###xml 215 219 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Jamieson1">[16]</xref>
###xml 220 224 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Nwe1">[18]</xref>
###xml 72 77 <span type="species:ncbi:9606">women</span>
###xml 110 116 <span type="species:ncbi:9606">humans</span>
Circulating cortisol levels are unaltered in post- versus premenopausal women [14]. Although not confirmed in humans [15], E2 attenuates 11betaHSD1 expression and enzyme activity in the liver and testis of rodents, [16]-[18]. This suggest that the dysmetabolic features including fat redistribution, elevated blood pressure, and dyslipidemia commonly seen after menopause may at least partly be mediated through tissue-specific alterations in cortisol levels via increased 11betaHSD1.
###end p 7
###begin p 8
###xml 154 159 <span type="species:ncbi:9606">women</span>
We hypothesized that 11betaHSD1 expression and activity are increased in adipose tissue and/or liver in postmenopausal versus premenopausal normal weight women.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
Subjects
###end title 10
###begin p 11
###xml 73 78 <span type="species:ncbi:9606">women</span>
###xml 284 291 <span type="species:ncbi:4097">tobacco</span>
###xml 426 431 <span type="species:ncbi:9606">women</span>
###xml 504 509 <span type="species:ncbi:9606">woman</span>
###xml 595 600 <span type="species:ncbi:9606">women</span>
Twenty-three premenopausal and 23 postmenopausal, healthy, normal weight women were recruited by advertisements in the local newspapers and within the Umea University Hospital and campus areas. Exclusion criteria were: diabetes, thyroid dysfunction, hepatic and renal disease, use of tobacco, hormonal contraceptives, systemic gonadal hormone replacement therapy, or oral glucocorticoid medication. None of the postmenopausal women reported menstrual periods within the last 12 months. One premenopausal woman used inhaled steroids for asthma (budesonide, 400 microg/24 h). Three postmenopausal women had well-controlled hypertension treated with beta-blockers, diuretics, or calcium antagonist, one took tolterodine for urinary incontinence and bisphosphonates for osteoporosis, and two used topical E2 or estriol treatment.
###end p 11
###begin title 12
Ethics Statement
###end title 12
###begin p 13
The study was approved by the Umea University Ethical Committee and all subjects gave written, informed consent before entering the study.
###end p 13
###begin title 14
Clinical protocol
###end title 14
###begin p 15
###xml 14 19 <span type="species:ncbi:9606">women</span>
Premenopausal women were evaluated during both follicular and luteal phases of the menstrual cycle to investigate the possible effects of hormonal fluctuations. Menstrual phase or postmenopausal status was confirmed by measuring serum E2 and progesterone levels. Anthropometric measurements, urine collections, adipose tissue biopsies, and hepatic cortisone conversion tests were performed on separate days.
###end p 15
###begin p 16
Weight to the nearest 0.1 kg (with subjects wearing light clothes) and height and waist circumference to the nearest 0.5 cm was measured. Blood pressure was measured in the sitting position after 5 minutes rest with a mercury sphygmomanometer.
###end p 16
###begin p 17
Urine was collected for 24 h, measured to the nearest ml, and aliquots stored without preservatives at -20degreesC until analyzed.
###end p 17
###begin p 18
Approximately 2 g of periumbilical superficial subcutaneous adipose tissue was excised under local anaesthesia with lidocaine (Xylocaine(R) without adrenaline, AstraZeneca, Sweden) after an overnight fast. Tissue was snap frozen in liquid nitrogen within 5 minutes after removal, and stored at -80degreesC until further analyses.
###end p 18
###begin p 19
For the hepatic cortisone conversion test, the subjects took an oral dose of 1 mg dexamethasone (2 tablets of 0.5 mg Decadrone(R), Merck & Co., Sweden) at 2300 h in order to suppress endogenous cortisol production and fasted overnight. Venous blood samples for baseline cortisol levels were drawn at approximately 0800-0900 h, followed by 25 mg oral cortisone acetate (Cortal(R) 25 mg, N.V. Organon Oss Holland). Blood samples for serum cortisol analyses were then drawn every 30 minutes during the following four hours.
###end p 19
###begin p 20
Venous blood samples for routine laboratory tests were drawn at the time of anthropometric measurements. Venous blood samples for serum analyses (described below) were drawn in the mornings of the adipose tissue biopsies and cortisone conversion tests after at least eight hours of fasting.
###end p 20
###begin title 21
Laboratory Methods
###end title 21
###begin title 22
RNA extraction and quantification
###end title 22
###begin p 23
Total RNA was extracted according to the manufacturer's instructions from approximately 450 mg of adipose tissue using the RNeasy(R) lipid tissue midi kit (Qiagen Nordic, Qiagen House, West Sussex, UK). RNA concentrations were measured on a ND-1000 Spectrophotometer (NanoDrop Technologies, Bancroft Building, Wilmington, DE, USA) and integrity was evaluated on a 1% agarose electrophoretic gel and visualized with ethidium bromide under UV-light.
###end p 23
###begin p 24
###xml 1104 1108 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Gabrielsson1">[19]</xref>
###xml 1074 1079 <span type="species:ncbi:9606">human</span>
SpectrophotometerTwo micrograms of RNA was reverse transcribed using TaqMan(R) Reverse Transcription Reagents (Roche Molecular Systems, Inc., Branchburg, NJ, USA). Real-time PCR was carried out on an ABI Prism(R) 7000 Sequence Detection System (Applied Biosystems) according to manufacturer's instructions using Universal PCR Master Mix 2X (Roche Molecular Systems, Inc., Branchburg, NJ, USA) and TaqMan Gene expression assays for target genes 11betaHSD1 (assay No. Hs00194153_m1), aromatase (assay No. Hs00240671_m1), and the endogenous control Cyclophilin A (PPIA) (assay No. Hs99999904_m1) (Applied Biosystems, Foster City, CA, USA). All reactions were performed in triplicate and non-template controls were included on every plate. A standard curve was included on each plate for relative quantification. Data were normalized against PPIA, which had the lowest coefficient of variation and the best stability value, based on the Normfinder algorithm () out of three tested endogenous controls (PPIA, LRP10 and RPLP0, data not shown), previously found to be suitable for human adipose tissue analyses [19].
###end p 24
###begin title 25
In vitro adipose 11betaHSD1 enzyme activity assay
###end title 25
###begin p 26
###xml 188 192 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Livingstone1">[20]</xref>
###xml 194 198 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask2">[21]</xref>
###xml 657 658 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 660 661 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 976 979 951 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">254</sub>
11betaHSD1 protein in adipose tissue was quantified by measuring enzyme activity in the dehydrogenase direction, which is the preferred reaction in tissue homogenates with excess cofactor [20], [21]. Adipose tissue (300 mg) was homogenized in 900 microl ice-cold buffer (10% glycerol, 300 mM NaCl, 1 mM EDTA, 50 mM Tris, pH 7.4) and 0.1 mM dithiothreitol and centrifuged at 12,000xg for 15 min at 4degreesC. Total protein concentrations were determined using the Bradford technique (Bio-Rad protein assay, Bio-Rad Laboratories Inc., Herculus, CA, USA). Duplicate samples of 3 mg/ml of protein were incubated at 37degreesC with 10 mM NADP and 50 nM [1,2,6,7-3H]4-cortisol for 24 h. Samples were withdrawn at 12, 16, 20, and 24 h and frozen at -80degreesC. Subsequently, glucocorticoids were extracted with dichloromethane, the organic phase evaporated, extracts dissolved in ethanol and separated by thin layer chromatography (on TLC aluminium sheets, 20x20 cm, Silica gel 60 F254, Merck KGaA, Darmstadt, Germany, mobile phase; chloroform and ethanol (92:8)). Radio-labelled glucocorticoids were detected by exposure of the TLC sheet to a tritium storage phosphor screen, subsequently scanned in a Typhoontrade mark 9400 scanner (both GE Healthcare Europe GmbH, Germany). 11betaHSD1 activity was expressed as percent conversion of cortisol to cortisone.
###end p 26
###begin title 27
Urinary corticosteroid metabolites
###end title 27
###begin p 28
###xml 221 225 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Best1">[22]</xref>
Cortisol, cortisone, 5alpha-tetrahydrocortisol (5alpha-THF), 5beta-THF, and 5beta-tetrahydrocortisone (THE) concentrations were analyzed by gas chromatography and electron impact mass spectrometry as previously described [22].
###end p 28
###begin title 29
Serum analyses
###end title 29
###begin p 30
Liver transaminases were measured in the samples drawn at the time of anthropometric measurements (menstrual phase not determined). Estradiol, progesterone and cortisol were measured in samples drawn both at the biopsy and at the cortisone conversion test. All other analyses were made in samples drawn on the morning of the adipose tissue biopsy to avoid interference with the dexamethasone suppression administered in advance of the cortisol conversion test. Serum cortisol, progesterone, sex hormone-binding globulin (SHBG), and insulin were analyzed by electrochemiluminescence immunoassays, on a Modular Analytics E170 (all from Roche AB, Stockholm, Sweden). Serum free testosterone was measured using a radioimmunoassay, Coat-a-count(R), (Siemens Healthcare Diagnostics, Deerfield, IL, USA). Glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST), cholesterol, triglycerides, and HDL and LDL cholesterol were analyzed on a VITROS(R) Ektachem 950 IRC (Johnson & Johnson, Langhorne, PA, USA) using colorimetric assays. Apolipoprotein A1 (ApoA1) and Apo B was analyzed with immunoturbidimetric technique on a Hitachi 911 analyzer (Roche AB, Stockholm, Sweden). HOMA-IR (Homeostasis Model Assessment for Insulin Resistance) was calculated using the HOMA calculator v2.2 available at . E2 was measured using an ultra sensitive radioimmunoassay (ESTR-US-CT, CIS bio international, Gif-sur-Yvette, Cedex, France) (intra- and interassay coefficients of variation (CV); 2.8-18.1% and 5.8-17.6%, respectively).
###end p 30
###begin title 31
Statistical Analyses
###end title 31
###begin p 32
###xml 397 402 <span type="species:ncbi:9606">women</span>
###xml 932 937 <span type="species:ncbi:9606">women</span>
Data are shown as mean+/-SD, unless otherwise indicated, and were natural log-transformed when necessary to achieve normal distribution. Student's t-tests were used to compare means between the groups and paired Student's t-tests to compare follicular and luteal phase samples in the premenopausal group. Associations between variables, including follicular phase premenopasual and postmenopausal women, were examined with Pearson correlation tests with adjustments for waist circumference, BMI, and menopausal status in partial correlation analyses. The effect of, and possible interaction between, waist circumference or BMI and menopausal status was tested with linear regression. Repeated-measures ANOVA was employed to test the effect of menopausal status on adipose enzyme activity. Statistical calculations were carried out using the SPSS software (release 14.0.1, SPSS Inc., 233 S. Wacker Drive, Chicago, IL). Premenopausal women found not to be in the anticipated menstrual phase were excluded in the statistical calculations for that particular test.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 25 33 25 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t001">Tables 1</xref>
###xml 38 39 38 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t002">2</xref>
Subject Characteristics (Tables 1 and 2)
###end title 34
###begin p 35
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 316 319 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 620 623 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 182 187 <span type="species:ncbi:9606">women</span>
###xml 410 415 <span type="species:ncbi:9606">women</span>
###xml 506 511 <span type="species:ncbi:9606">women</span>
BMI and waist circumference did not differ between the menopausal groups. E2, progesterone, and free testosterone levels were significantly lower in postmenopausal vs. premenopausal women regardless of menstrual phase. Systolic blood pressure, serum total cholesterol and cholesterol sub-fractions (except HDL; only vs. luteal phase), triglyceride levels, and liver transaminases were higher in postmenopausal women, while HOMA-IR was lower, mainly due to lower fasting insulin levels among postmenopausal women. Within the menstrual cycle, LDL, apolipoprotein B, and cholesterol levels were increased in the follicular vs. luteal phase.
###end p 35
###begin title 36
Subject characteristics.
###end title 36
###begin p 37
SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT alanine aminotransferase; HOMA-IR, Homeostasis Model Assessment for Insulin Resistance.
###end p 37
###begin p 38
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">***</sup>
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>***</sup>P&lt;</italic>
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 40 45 <span type="species:ncbi:9606">women</span>
P<0.01 and ***P<0.001 vs. premenopausal women.
###end p 38
###begin title 39
Circulating levels of steroids and lipids and adipose aromatase transcript levels.
###end title 39
###begin p 40
###xml 4 9 <span type="species:ncbi:9606">woman</span>
###xml 117 122 <span type="species:ncbi:9606">women</span>
One woman in follicular phase and three in the luteal phase of the menstrual cycle did not have the biopsy and three women in each premenopausal group were found not to be in the correct menstrual phase. 11betaHSD1, 11beta-hydroxyteroid dehydrogenase type 1; PPIA, Cyclophilin A; SHBG, Sex hormone-binding globulin; HDL, high-density lipoprotein; LDL low-density lipoprotein; ApoA1, Apolipoprotein A-1; ApoB, Apolipoprotein B. N = 16 for luteal phase blood lipid data.
###end p 40
###begin p 41
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</sup>
###xml 10 12 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 20 24 20 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> ***</sup>
###xml 24 26 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
P<0.05, **P<0.01 and ***P<0.001 vs. follicular phase.
###end p 41
###begin p 42
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 8 20 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;&#8224;</sup>
###xml 20 22 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 30 49 20 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &#8224;&#8224;&#8224;</sup>
###xml 49 51 24 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 57 60 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
P<0.05, daggerdaggerP<0.01 and daggerdaggerdaggerP<0.001 vs. luteal phase.
###end p 42
###begin title 43
###xml 36 43 36 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t003">Table 3</xref>
Urinary Corticosteroid Metabolites (Table 3)
###end title 43
###begin p 44
###xml 232 235 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 524 525 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 557 558 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 606 607 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 718 725 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
###xml 250 255 <span type="species:ncbi:9606">women</span>
###xml 342 347 <span type="species:ncbi:9606">women</span>
###xml 743 748 <span type="species:ncbi:9606">women</span>
###xml 807 812 <span type="species:ncbi:9606">women</span>
###xml 908 913 <span type="species:ncbi:9606">women</span>
Total glucocorticoid urinary metabolite excretion did not differ between groups, indicative of unaltered glucocorticoid production rate with menopause. The (5alpha-THF+5beta-THF)/THE ratio was significantly higher in postmenopausal vs. premenopausal women in luteal phase, indicating a higher total body 11betaHSD1 activity in postmenopausal women; this difference remained after adjustment for BMI and waist circumference. The (5alpha-THF+5beta-THF)/THE ratio correlated positively with diastolic blood pressure (R = 0.34, P<0.05) and serum LDL (R = 0.31, P<0.05) and negatively with serum E2 (R = -0.34, P<0.05); these associations did not remain after adjustment for BMI, waist circumference, and menopausal group (Table 4). Postmenopausal women had higher urinary 5beta-THF excretion than premenopausal women regardless of menstrual phase, with lower 5alpha-THF/5beta-THF ratio compared to premenopausal women in the follicular phase; these differences persisted after adjustment for waist circumference and BMI.
###end p 44
###begin title 45
Urinary corticosteroid metabolites.
###end title 45
###begin p 46
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 316 320 316 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> ***</sup>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 6 11 <span type="species:ncbi:9606">women</span>
###xml 114 119 <span type="species:ncbi:9606">woman</span>
###xml 209 214 <span type="species:ncbi:9606">women</span>
###xml 233 238 <span type="species:ncbi:9606">woman</span>
Three women in each premenopausal group were found not to be in the anticipated phase of the menstrual cycle, one woman in follicular phase did not comply with the instructions of the urine collection and two women in luteal and one woman in follicular phase of the menstrual cycle did not collect urine. *P<0.05 and ***P<0.001 vs. follicular phase.
###end p 46
###begin p 47
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 11 23 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;&#8224;</sup>
###xml 23 24 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 30 33 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
P<0.05 and daggerdaggerP<0.01 vs. luteal phase. THF, tetrahydrocortisol; THE, tetrahydrocortisone.
###end p 47
###begin title 48
Bivariate correlations for adipose 11betaHSD1 expression and activity, urinary THFs/THE and hepatic 11betaHSD1 activity versus anthropometric data, sex steroids, hormones and gene expression of aromatase.
###end title 48
###begin p 49
###xml 14 19 <span type="species:ncbi:9606">women</span>
###xml 82 87 <span type="species:ncbi:9606">women</span>
Premenopausal women in follicular phase of the menstrual cycle and postmenopausal women were included. Enzyme activity was measured as percent conversion of cortisol to cortisone after 24 h incubation. Urinary THFs/THE gives a measure of whole body 11betaHSD1 activity. Hepatic 11betaHSD1 activity was measured as serum cortisol 30 minutes after oral cortisone. 11betaHSD1, 11beta-hydroxysteroid dehydrogenase type 1; EA, Enzyme activity; THFs/THE, (5alpha-tetrahydrocortisol+5beta-tetrahydrocortisol)/5beta-tetrahydrocortione; SBP, systolic blood pressure; DBP, diastolic blood pressure, n.a., not applicable. Data are correlation coefficients (Pearson correlation).
###end p 49
###begin p 50
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">**</sup>
###xml 10 12 10 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> ***</sup>
###xml 25 27 25 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;</italic>
P<0.05, **P<0.01, and ***P<0.001.
###end p 50
###begin p 51
Association significant after adjusting for waist circumference, BMI, and menopausal group (partial correlation).
###end p 51
###begin title 52
11betaHSD1 in Subcutaneous Adipose Tissue
###end title 52
###begin p 53
###xml 69 71 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 114 121 111 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008475-g001">Fig. 1A</xref>
###xml 188 191 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 317 318 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 339 346 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
###xml 500 504 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 514 515 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 526 530 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 541 542 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 20 25 <span type="species:ncbi:9606">women</span>
###xml 139 144 <span type="species:ncbi:9606">women</span>
###xml 223 228 <span type="species:ncbi:9606">women</span>
Among premenopausal women 11betaHSD1 expression was higher in luteal vs. follicular phase of the menstrual cycle (Fig. 1A). Postmenopausal women had a higher adipose 11betaHSD1 expression vs. follicular phase premenopausal women. 11betaHSD1 expression in adipose tissue correlated with waist circumference (R = 0.56, P<0.001) but not BMI (Table 4). Linear regression analysis showed that waist circumference and menopausal group both independently affect the 11betaHSD1 expression in adipose tissue; beta = 0.493, P<0.001 and beta = -0.298, P<0.05, respectively.
###end p 53
###begin title 54
Subcutaneous adipose tissue 11betaHSD1.
###end title 54
###begin p 55
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 85 86 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 96 97 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 522 523 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 912 913 815 816 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 266 271 <span type="species:ncbi:9606">woman</span>
###xml 379 384 <span type="species:ncbi:9606">women</span>
###xml 776 781 <span type="species:ncbi:9606">women</span>
###xml 1201 1206 <span type="species:ncbi:9606">women</span>
A 11betaHSD1 transcript levels were normalized to endogenous control Cyclophilin A. *P<0.05, ** P<0.01, N = 19, 17, and 23 for the premenopausal follicular (square), luteal (blacksquare, square, filled), and postmenopausal (black triangle) groups, respectively. One woman in follicular phase and three in the luteal phase of the menstrual cycle did not have the biopsy and three women in each premenopausal group were found not to be in the correct phase. Data were natural log-transformed to achieve normal distribution. B Correlation between adipose 11betaHSD1 activity after 24 hr incubation (percent conversion) and adipose 11betaHSD1 mRNA expression (relative to Cyclophilin A). Premenopausal follicular (square), luteal (blacksquare, square, filled), and postmenopausal women (black triangle). Linear regression line is shown for the postmenopausal group, dotted lines denotes the 95% confidence interval. C Subcutaneous adipose tissue 11betaHSD1 activity was measured as percent conversion of cortisol to cortisone over time in tissue homogenates, protein concentration 3 mg/ml. N = 13, 10, and 20 for premenopausal follicular (square), luteal (blacksquare, square, filled), and postmenopausal women (black triangle), respectively. There were no significant differences between the groups. Data were ln-transformed to achieve normal distribution and are shown as means+/-SEM.
###end p 55
###begin p 56
###xml 87 94 81 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008475-g001">Fig. 1B</xref>
###xml 145 152 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008475-g001">Fig. 1C</xref>
###xml 233 234 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 304 311 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
11betaHSD1 enzyme activity showed a close correlation with 11betaHSD1 mRNA expression (Fig. 1B) but did not differ significantly between groups (Fig. 1C). Enzyme activity was positively associated with waist circumference (R = 0.66, P<0.001), this remained after adjustment for BMI and menopausal group (Table 4).
###end p 56
###begin p 57
###xml 153 160 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
###xml 230 237 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
###xml 558 565 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
11betaHSD1 expression correlated positively with systolic blood pressure, cholesterol, LDL cholesterol, triglycerides, and adipose aromatase expression (Table 4). In addition there was a negative correlation with HDL cholesterol (Table 4). Of these correlations, only the associations with aromatase and HDL cholesterol remained after adjustment for BMI, waist circumference, and menopausal group. A similar pattern was shown for adipose 11betaHSD1 activity which correlated positively with LDL cholesterol and aromatase and negatively with HDL cholesterol (Table 4); only the latter remained after adjustments.
###end p 57
###begin title 58
In Vivo Hepatic 11betaHSD1 Activity
###end title 58
###begin p 59
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 184 190 184 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008475-g002">Fig. 2</xref>
###xml 97 102 <span type="species:ncbi:9606">women</span>
###xml 122 127 <span type="species:ncbi:9606">women</span>
###xml 441 446 <span type="species:ncbi:9606">women</span>
At 30 minutes post oral cortisone ingestion, serum cortisol levels were higher in postmenopausal women than premenopausal women in the follicular phase of the menstrual cycle (P<0.01, Fig. 2); the difference remained after adjustment for BMI and waist circumference. This indicates a faster conversion of cortisone to cortisol on first pass through the liver, suggesting increased hepatic 11betaHSD1 reductase activity in the postmenopausal women.
###end p 59
###begin title 60
Hepatic 11betaHSD1 activity.
###end title 60
###begin p 61
###xml 297 298 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 310 311 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 336 339 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs.</italic>
###xml 114 119 <span type="species:ncbi:9606">women</span>
###xml 229 234 <span type="species:ncbi:9606">women</span>
Serum cortisol levels after overnight dexamethasone suppression and oral cortisone intake (25 mg). Postmenopausal women (black triangle, N = 23) had higher serum cortisol levels at 30 min post cortisone intake than premenopausal women in follicular phase of the menstrual cycle (square, N = 17). *P<0.05 and **P<0.01 for postmenopausal vs. premenopausal follicular phase. Luteal phase, blacksquare, square, filled, N = 16. Data are means+/-SEM.
###end p 61
###begin p 62
###xml 333 340 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
###xml 446 453 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008475-t004">Table 4</xref>
Similar to the measures of adipose 11betaHSD1, serum cortisol levels at 30 min post cortisone ingestion, correlated positively with systolic blood pressure, serum cholesterol, and LDL cholesterol. The associations to serum cholesterol and LDL cholesterol remained after adjustment for BMI, waist circumference, and menopausal group (Table 4). There were also negative correlations with serum estradiol and testosterone levels before adjustments (Table 4).
###end p 62
###begin title 63
Discussion
###end title 63
###begin p 64
###xml 19 24 <span type="species:ncbi:9606">women</span>
###xml 477 482 <span type="species:ncbi:9606">women</span>
###xml 981 986 <span type="species:ncbi:9606">women</span>
The postmenopausal women in this study had a higher urinary cortisol/cortisone metabolites ratio suggestive of increased total body 11betaHSD1 activity. Importantly, we found higher transcript levels of the glucocorticoid-generating enzyme 11betaHSD1 in subcutaneous fat with concomitantly increased first-pass conversion of cortisone to cortisol, suggesting increased hepatic 11betaHSD1 activity. These findings support an elevation in 11betaHSD1 activity in older menopausal women in both adipose tissue and liver, resulting in a tissue-specific increase in glucocorticoid exposure despite unaltered circulating cortisol levels. Waist circumference was closely linked with increased adipose tissue 11betaHSD1 transcript levels and enzyme activity. However, 11betaHSD1 transcript levels in adipose tissue were also independently affected by menopausal/age group. Additionally, the differences in hepatic and whole-body 11betaHSD1 activity between premenopausal and postmenopausal women were independent of waist circumference, suggesting an effect of age/menopausal group over and above the associations between centralization of body fat and 11betaHSD1.
###end p 64
###begin p 65
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Dubuc1">[23]</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Genazzani1">[24]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Dubuc1">[23]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Genazzani1">[24]</xref>
###xml 728 732 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Dieudonne1">[25]</xref>
###xml 733 737 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Paulsen1">[27]</xref>
###xml 216 222 <span type="species:ncbi:9606">humans</span>
###xml 421 426 <span type="species:ncbi:9606">women</span>
###xml 668 673 <span type="species:ncbi:9606">women</span>
Whether these changes are related to age and/or menopause per se cannot be determined from this cross-sectional study. Notably, decreased circulating estrogen levels due to ovariectomy or menopause in rodents and/or humans results in increased body fat mass with central distribution [23], [24]. This change in body composition, linked to insulin resistance and increased risk of cardiovascular disease in postmenopausal women, can be reversed by estrogen replacement therapy [23], [24]. However, data from studies of the effects of estrogen on 11betaHSD1 in adipose tissue are sparse and partly conflicting, and included mixed cohorts of both pre- and postmenopausal women, with varying BMI, and/or a limited number of samples [25]-[27]. In our study serum E2 levels correlated negatively with measures of both whole body and hepatic 11betaHSD1 activity, supporting a down-regulatory effect of E2. However, this is confounded by putative effects of age/menopausal status and body composition. Notably, we did not find an association between serum E2 levels and adipose 11betaHSD1 expression or activity, which may suggest tissue-specific differences in the interaction between estrogen and 11betaHSD1.
###end p 65
###begin p 66
###xml 298 302 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Dieudonne1">[25]</xref>
###xml 304 308 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Misso1">[28]</xref>
###xml 539 543 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Zhao1">[29]</xref>
###xml 178 183 <span type="species:ncbi:9606">women</span>
In contrast, we found a positive association between aromatase and 11betaHSD1 gene expression in adipose tissue, independent of adiposity and menopausal group. In postmenopausal women, aromatase activity is the main source of E2, and aromatase expression has been shown to increase after menopause [25], [28]. The positive correlation with aromatase hence suggests an up-regulatory effect of E2 on 11betaHSD1 expression in adipose tissue, but this may also be related to glucocorticoids driving the promoter activity of the aromatase gene [29]. Therefore, our observations regarding E2 and 11betaHSD1 are inconsistent and need further investigation to elucidate whether estrogen deficiency underpins elevated 11betaHSD1 in the postmenopausal state.
###end p 66
###begin p 67
###xml 115 119 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Tomlinson1">[30]</xref>
###xml 233 237 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Pfeilschifter1">[31]</xref>
###xml 327 331 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Tomlinson2">[32]</xref>
###xml 999 1003 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Finken1">[15]</xref>
###xml 751 756 <span type="species:ncbi:9606">women</span>
There are alterations in cytokines and other hormones with age and menopause which may influence 11betaHSD1 levels [30]. With menopause there is an increased immune activation with increased serum levels of proinflammatory cytokines [31]. Interestingly, cytokines such as TNF-alpha influence 11betaHSD1 expression and activity [32], and it would therefore be of interest to study possible associations between immune responses and glucocorticoid activation in these subjects. An alternative explanation related to menopausal status is progesterone deficiency, which has not been studied in detail. Notably, we did not find any associations between serum progesterone levels and measures of 11betaHSD1 expression/activity. However, among premenopausal women adipose 11betaHSD1 expression was higher in the luteal phase of the menstrual cycle, which is characterized by high serum estrogen and progesterone levels, compared to the follicular phase. On the other hand, consistent with previous studies [15] we did not find differences in urinary steroid ratios, or liver 11betaHSD1 activity within the menstrual cycle. Further experimental analyses of the role of progesterone in tissue-specific glucocorticoid activation therefore seem warranted.
###end p 67
###begin p 68
###xml 457 461 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask2">[21]</xref>
###xml 569 572 557 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask1">[9]</xref>
###xml 574 578 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask2">[21]</xref>
11betaHSD1 activity and mRNA expression in adipose tissue were strongly correlated but there was no significant difference in 11betaHSD1 activity between groups. The lack of a statistically significant difference may at least partly be due to low power as there were fewer samples available for these analyses due to lack of tissue homogenate. Importantly, 11betaHSD1 activity is relatively low in this BMI range (compared to levels seen in obese subjects, [21]) and in line with this, the previously reported association between 11betaHSD1 activity/expression and BMI [9], [21] was not detected in this study cohort.
###end p 68
###begin p 69
###xml 358 361 352 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask1">[9]</xref>
###xml 363 367 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Livingstone1">[20]</xref>
###xml 369 373 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask2">[21]</xref>
###xml 556 560 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Johansson1">[33]</xref>
###xml 134 139 <span type="species:ncbi:9606">women</span>
###xml 523 531 <span type="species:ncbi:9606">patients</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
###xml 689 694 <span type="species:ncbi:9606">women</span>
Our results from the hepatic cortisone-to-cortisol conversion test indicate higher 11betaHSD1 activity in the liver of postmenopausal women. This contrast with previous observations in overweight individuals, where we and others have suggested a reduced 11betaHSD1 activity in liver in combination with up-regulation of activity/expression in adipose tissue [9], [20], [21]. Interestingly, gonadal dysfunction and increased body fat percentage with normal body weight is linked to increased hepatic cortisone conversion in patients with myotonic dystrophy [33]. These patients develop fatty livers and, although liver fat content was not estimated in the present study, the postmenopausal women of our study had significantly higher serum levels of liver enzymes (AST, ALT), which is linked to increased liver fat content.
###end p 69
###begin p 70
###xml 518 521 509 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask1">[9]</xref>
###xml 523 527 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Rask2">[21]</xref>
###xml 1560 1564 1526 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Andrew1">[34]</xref>
###xml 204 209 <span type="species:ncbi:9606">women</span>
###xml 455 460 <span type="species:ncbi:9606">women</span>
###xml 514 517 <span type="species:ncbi:9606">men</span>
###xml 956 961 <span type="species:ncbi:9606">women</span>
The balance between cortisol and cortisone and their metabolites in urine has often been used as an estimation of the whole body activity of 11betaHSD1. We found a higher THFs/THE ratio in postmenopausal women, which is in part explained by their higher 5betaTHF levels. This is consistent with an overall increase in 11betaHSD1 activity with menopause/older age, and similar to what we have previously observed with increasing BMI in pre-/perimenopausal women, but contrary to the findings in a parallel study in men [9], [21]. However, we did not find an association between the THFs/THE ratio and BMI and we only saw a trend towards a positive correlation with waist circumference. Notably, the urinary THFs/THE ratio does not distinguish the activities of 11betaHSD type 1 and 2, the latter which catalyses the deactivation of cortisol to cortisone. Moreover, the changes in 5alpha-THF/5beta-THF ratio and of 5beta-THF/cortisol ratio in postmenopausal women raise the possibility of confounding effects due to variation in 5beta-reductase activity. Increased 5beta-reductase would be expected to decrease, rather than increase, the plasma cortisol values after oral cortisone. With the hepatic cortisone-to-cortisol conversion-test data in mind we therefore conclude that there is increased liver 11betaHSD1 activity after the menopause but this may not be the only reason for alterations in urinary cortisol metabolite ratios. There is thus a need for further studies using isotopically labelled cortisol to evaluate whole body 11betaHSD1 enzyme activity [34].
###end p 70
###begin p 71
###xml 469 473 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Livingstone1">[20]</xref>
###xml 475 479 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Andersson1">[35]</xref>
###xml 480 484 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Veilleux1">[41]</xref>
###xml 400 405 <span type="species:ncbi:9606">human</span>
Unfortunately we did not have the opportunity to assess visceral adipose tissue expression and activity of 11betaHSD1. This would have been most interesting especially with regard to the redistribution of adipose tissue commonly seen with menopause with increased abdominal depots. Although animal studies indicate higher 11betaHSD1 levels in the visceral adipose tissue, at least with obesity, some human studies have shown higher expression in the subcutaneous depot [20], [35]-[41].
###end p 71
###begin p 72
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Masuzaki1">[11]</xref>
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Paterson1">[13]</xref>
###xml 670 674 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008475-Walton1">[42]</xref>
###xml 39 54 <span type="species:ncbi:10090">transgenic mice</span>
###xml 479 484 <span type="species:ncbi:9606">women</span>
###xml 625 630 <span type="species:ncbi:9606">women</span>
###xml 789 794 <span type="species:ncbi:9606">women</span>
###xml 920 925 <span type="species:ncbi:9606">women</span>
In accordance with previous studies in transgenic mice [11]-[13] we found that, overall, higher 11betaHSD1 was associated with higher blood pressure and a less beneficial blood lipid profile; higher total cholesterol, low-density lipoprotein, and triglycerides and lower high-density lipoprotein, which links to increased risk of cardiovascular disease. However, we did not find any associations with insulin or glucose. Rather, the lower HOMA-IR indices found in postmenopausal women was mainly due to lower fasting insulin levels in this group. Interestingly, insulin secretion is lower in postmenopausal vs. premenopausal women and this may contribute to our finding [42]. However, this observation may also be explained by genetic factors, diet and/or exercise habits, since the older women have managed to remain lean past the menopause. It should thus be considered that by recruiting normal weight postmenopausal women we may have introduced a bias in this cohort.
###end p 72
###begin p 73
###xml 103 108 <span type="species:ncbi:9606">women</span>
###xml 311 316 <span type="species:ncbi:9606">women</span>
In conclusion, we suggest that menopause/older age linked to central fat distribution in normal weight women is associated with increased tissue-specific glucocorticoid exposure via 11betaHSD1. This may contribute to dysmetabolic changes linked to the increased risk of cardiovascular disease in postmenopausal women.
###end p 73
###begin p 74
We thank Drs Cecilia Nordensson and Anders Kristoffersson for performing the adipose tissue biopsies, research nurses Veronika Sjogren, Britt-Inger Norberg, and Inger Arnesjo for excellent assistance with recruiting the subjects and the clinical measurements, and Jill Harrison for excellent technical assistance with gas chromatographic mass spectrometric analyses.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
Reproductive history in relation to relative weight and fat distribution.
###end article-title 76
###begin article-title 77
Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study.
###end article-title 77
###begin article-title 78
The emergence of the metabolic syndrome with menopause.
###end article-title 78
###begin article-title 79
###xml 56 68 <span type="species:ncbi:9606">participants</span>
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.
###end article-title 79
###begin article-title 80
Molecular and cellular basis of cardiovascular gender differences.
###end article-title 80
###begin article-title 81
Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
###end article-title 81
###begin article-title 82
Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
###end article-title 82
###begin article-title 83
###xml 160 163 <span type="species:ncbi:9606">men</span>
Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
###end article-title 83
###begin article-title 84
###xml 67 72 <span type="species:ncbi:9606">women</span>
Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
###end article-title 84
###begin article-title 85
###xml 131 135 <span type="species:ncbi:10090">mice</span>
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.
###end article-title 85
###begin article-title 86
A transgenic model of visceral obesity and the metabolic syndrome.
###end article-title 86
###begin article-title 87
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.
###end article-title 87
###begin article-title 88
###xml 108 123 <span type="species:ncbi:10090">transgenic mice</span>
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.
###end article-title 88
###begin article-title 89
###xml 91 96 <span type="species:ncbi:9606">women</span>
24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment.
###end article-title 89
###begin article-title 90
Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
###end article-title 90
###begin article-title 91
Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.
###end article-title 91
###begin article-title 92
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns.
###end article-title 92
###begin article-title 93
Differential regulation of the oxidative 11beta-hydroxysteroid dehydrogenase activity in testis and liver.
###end article-title 93
###begin article-title 94
###xml 64 69 <span type="species:ncbi:9606">human</span>
Evaluation of reference genes for studies of gene expression in human adipose tissue.
###end article-title 94
###begin article-title 95
###xml 127 131 <span type="species:ncbi:10116">rats</span>
Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.
###end article-title 95
###begin article-title 96
###xml 56 61 <span type="species:ncbi:9606">human</span>
Tissue-specific dysregulation of cortisol metabolism in human obesity.
###end article-title 96
###begin article-title 97
Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo.
###end article-title 97
###begin article-title 98
###xml 87 91 <span type="species:ncbi:10116">rats</span>
Effects of estradiol implants on body weight regulation in castrated and intact female rats.
###end article-title 98
###begin article-title 99
Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
###end article-title 99
###begin article-title 100
###xml 105 110 <span type="species:ncbi:9606">human</span>
Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities.
###end article-title 100
###begin article-title 101
###xml 34 39 <span type="species:ncbi:9606">human</span>
Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
###end article-title 101
###begin article-title 102
###xml 97 101 <span type="species:ncbi:10116">rats</span>
Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
###end article-title 102
###begin article-title 103
###xml 54 59 <span type="species:ncbi:9606">women</span>
Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy.
###end article-title 103
###begin article-title 104
###xml 41 46 <span type="species:ncbi:9606">human</span>
Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.
###end article-title 104
###begin article-title 105
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
###end article-title 105
###begin article-title 106
Changes in proinflammatory cytokine activity after menopause.
###end article-title 106
###begin article-title 107
Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
###end article-title 107
###begin article-title 108
Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy.
###end article-title 108
###begin article-title 109
Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.
###end article-title 109
###begin article-title 110
###xml 123 127 <span type="species:ncbi:10116">Rats</span>
Estrogen Reduces 11beta-Hydroxysteroid Dehydrogenase Type 1 in Liver and Visceral, but Not Subcutaneous, Adipose Tissue in Rats.
###end article-title 110
###begin article-title 111
###xml 72 77 <span type="species:ncbi:9606">human</span>
Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue.
###end article-title 111
###begin article-title 112
###xml 119 127 <span type="species:ncbi:9606">children</span>
Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
###end article-title 112
###begin article-title 113
###xml 41 46 <span type="species:ncbi:9606">women</span>
Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial.
###end article-title 113
###begin article-title 114
Obesity Is Accompanied by Disturbances in Peripheral Glucocorticoid Metabolism and Changes in FA Recycling.
###end article-title 114
###begin article-title 115
Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
###end article-title 115
###begin article-title 116
###xml 142 147 <span type="species:ncbi:9606">women</span>
Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women.
###end article-title 116
###begin article-title 117
###xml 101 106 <span type="species:ncbi:9606">women</span>
The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Tommy Olsson has received a consulting fee from Wyeth Pharmaceuticals.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the Swedish Research Council (), the Swedish Heart-Lung Foundation (), the Swedish Diabetes Foundation (), Umea University (), and Vasterbotten County Council (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 119

